Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD
Methylphenidate (MPH) improves behavioral symptoms of attention-deficit/hyperactivity disorder (ADHD). Its effects on sleep, however, are insufficiently known, as trials with MPH in medication-naive children were so far restricted to relatively short trial durations. Here, we assessed effects of pro...
Main Authors: | Michelle M. Solleveld, Anouk Schrantee, Hee Kyung Baek, Marco A. Bottelier, Hyke G. H. Tamminga, Cheima Bouziane, Reino Stoffelsen, Paul J. Lucassen, Eus J. W. Van Someren, Roselyne M. Rijsman, Liesbeth Reneman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2020.00082/full |
Similar Items
-
Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
by: Michelle M. Solleveld, et al.
Published: (2017-01-01) -
The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder
by: A Schrantee, et al.
Published: (2017-01-01) -
ADHD and maturation of brain white matter: A DTI study in medication naive children and adults
by: Cheima Bouziane, et al.
Published: (2018-01-01) -
Sleep actigraphic patterns and cognitive status
by: Laura Buratti, et al.
Published: (2021-06-01) -
Actigraphic evaluation in patients with endometrial cancer
by: Tomoyuki Kawada
Published: (2016-08-01)